FDA Working with Patients to Explore Benefit/Risk: Opportunities & Challenges

U.S. Food and Drug Administration Inaugural Patient Network Annual Meeting

Hosted by FDA's Office of Special Health Issues (OSHI) in collaboration with the Center for Drug Evaluation and Research (CDER), the Center for Biologics Research and Evaluation (CBER), and the Center for Devices and Radiological Health (CDRH).

When: Friday, May 18, 2012, 9am-4:30pm (EST)
Where: FDA White Oak Campus
Building 31
10903 New Hampshire Avenue
Silver Spring, MD 20993
Cost: none

Register by: May 4, 2012

FDA seeks a greater understanding of how patients define and perceive benefits and risks
related to medical products. The FDA Patient Network is hosting this one-day meeting to:

  • review the drug and medical device regulatory processes;
  • discuss where patient input is practical and most valuable; and,
  • explore practical approaches to collecting meaningful patient input.

The meeting will include a series of presentations, exercises, and panel discussions to facilitate a
conversation with the patient community about these important topics.

Who Should Attend?
Patients/caregivers and patient advocates should attend. Members of the general public are
also invited to attend, including health professional, academia, and industry representatives.

The meeting will be webcast. To access the webcast, please register for the event and select the appropriate option.
Register now